Luciano Costa, MD, PhD, Discusses Final Results of the …
https://www.cancernetwork.com/view/luciano-costa-md-phd-discusses-final-results-of-the-master-trial-of-daratumumab-plus-krd-in-multiple-myeloma
WEBDec 14, 2021 · At the 2021 American Society of Hematology Annual Meeting, Luciano Costa, MD, PhD, associate director for Clinical Research at O’Neal Comprehensive Cancer Center, discussed the results of the phase 2 MASTER trial (NCT03224507), which examined daratumumab (Darzalex), carfilzomib (Kyprolis), lenalidomide (Revlimid), and …
DA: 17 PA: 31 MOZ Rank: 47